Clayton Dubilier & Rice is set to buy Sanofi's consumer health unit with social commitments, including job creation ...
That's especially true for people with high blood pressure. Many over-the-counter (OTC) painkillers can push your blood pressure higher. That can be dangerous. Since high blood pressure has no ...
Gemini is a free chatbot, search companion and more. Here's what you need to know about Google's AI tool. Barbara is a tech writer specializing in AI and emerging technologies. With a background ...
The U.S. Food and Drug Administration (FDA) has granted marketing authorization for the Healgen Rapid Check COVID-19/Flu A&B ...
These CRE-C10 Sony self-fitting OTC hearing aids have a replaceable battery that offers up to 70 hours of continuous use.
TULSA, Okla., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Ladybug Resource Group, Inc. (OTC PINK: $LBRG), now operating as Ladybug Nutratech, is excited to share an update on the development of its proprietary ...
Although manuka honey may not treat the underlying cause of psoriasis, research suggests it may help reduce skin inflammation ...
In September, the U.S. Food and Drug Administration approved Apple's Hearing Aid Feature (HAF). It is the first over-the-counter hearing aid software that can be used with a version of the AirPods Pro ...
Mankind Pharma has executed a Business Transfer Agreement (BTA) to transfer its Over-the-Counter (OTC) business undertaking to its wholly owned subsidiary, Mankind Consumer Products Private ...
On Sept. 26, the Hong Kong Monetary Authority (HKMA) and the Securities and Futures Commission (SFC) shared a plan to bring their OTC reporting requirements up to global standards after studying ...
As someone who's just wrapped up a masters degree, I can't help but feel a twinge of envy at the latest AI tools hitting the market. AI has improved in leaps and bounds in the last year ...
“In an intensely competitive obesity landscape, Rx to OTC could be a highly differentiated, valuable life-cycle management strategy to preserve substantial brand equity well beyond patent expiry ...